Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary ...

A urinary DNA methylation test demonstrated a high sensitivity for detecting high-grade or invasive bladder cancer, outperforming two other urine-based tests, a new study found.

The investigation of hematuria. Dtsch Arztebl Int. 2018 Nov 30;115(48):801-807. doi: 10.3238/arztebl.2018.0801. PMID: 30642428; PMCID: PMC6365675. Wang P, Zang S, Li G, Qu W, Li S, Qiao Q, Jiang Y.

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

in May 2024. The firm is a well-known multi-omics liquid biopsy provider that aims to improve the management of patients with hematuria and can detect bladder cancer early. The purpose of this ...

A DNA methylation test is one of several noninvasive biomarkers test under investigation for the early diagnosis of bladder cancer.

Here are the top 7 diseases that can lead to the leakage of blood via your urine. This one signs could indicate kidney ...

UGN-102 led to durable responses in low-grade, intermediate-risk bladder cancer, per phase 3 study findings at the 2025 ...